Angelo Di Leo cut his research teeth on the first studies that looked for biological markers that could predict which patients respond to what, and he’s never looked back.
Angelo Di Leo: mapping the geography of breast cancer
Marc Beishon
Related Articles
Highlight
TURNING POINT – “The panel recommends that bisphosphonates are considered as part of the adjuvant breast cancer treatment in postmenopausal women…”
Cutting Edge
Don’t shoot the driver! It’s about taxonomy more than targets
Featured